AI assistant
METLIFE INC — Director's Dealing 2019
May 1, 2019
29995_dirs_2019-05-01_3c30e0fc-c8aa-4a74-b25b-669405e9d79a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2019-05-01
Reporting Person: HUBBARD ROBERT GLENN (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-01 | Deferred Share Equivalents | $ | A | 283 | Acquired | Common Stock (283) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 54361 | Direct |
Footnotes
F1: The Reporting Person previously chose to defer his cash fees under the MetLife Deferred Compensation Plan for Non-Management Directors. The Reporting Person chose simulated investment in MetLife, Inc. common stock for a portion of those deferred cash fees. As a result, the Reporting Person acquired the Deferred Share Equivalents reported here. Each Deferred Share Equivalent (formerly referred to as Common Stock Equivalent Units) is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.
F2: The Reporting Person, a non-management director of MetLife, Inc., became Chairman of the Board of Directors on May 1, 2019. He previously served as Lead Director. Under MetLife, Inc.'s non-management director compensation arrangements, the Reporting Person's Board Chair cash fees for May 1 through June 17, 2019 became due on May 1. The Company reduced the amount due by the amount it previously paid the Reporting Person as Lead Director cash retainer fees for the same period.